Table 2 Prevalence of superantigens among isolates with antibiotic resistance
Antimicrobial susceptibility patterns | Types of SAgs | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
S | I | R | Antimicrobial agents | SEA (n = 2) | SEB (n = 25) | SEC (n = 44) | SED (n = 3) | SEE (n = 11) | SEH (n = 4) | SEM (n = 5) | TST1 (n = 23) |
42 (46.2) | – | 49 (53.8) | Fox | 2 | 13 | 28 | 0 | 5 | 2 | 4 | 13 |
49 (53.8) | – | 42 (46.2) | Sxt | 2 | 12 | 22 | 1 | 2 | 2 | 3 | 11 |
62 (68.1) | 3 (3.3) | 26 (28.6) | Ery | 1 | 8 | 13 | 1 | 1 | 0 | 2 | 5 |
73 (80.2) | – | 18 (19.8) | Cli | 0 | 4 | 7 | 0 | 2 | 1 | 0 | 2 |
64 (70.3) | 4 (4.4) | 23 (25.3) | Chl | 1 | 5 | 10 | 1 | 1 | 1 | 1 | 4 |
88 (96.7) | – | 3 (3.3) | Riph | 0 | 3 | 1 | 0 | 1 | 1 | 0 | 0 |
80 (87.9) | – | 11 (12.1) | Levo | 0 | 4 | 3 | 1 | 2 | 0 | 0 | 2 |
100 (100) | – | 0 | Vanco | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
65 (71.4) | 6 (6.6) | 20 (22) | Gen | 0 | 5 | 12 | 0 | 1 | 1 | 1 | 5 |
69 (75.8) | – | 22 (24.2) | Dox | 0 | 4 | 10 | 1 | 3 | 0 | 1 | 3 |
86 (94.5) | – | 5 (5.5) | Novo | 0 | 3 | 2 | 1 | 2 | 0 | 1 | 1 |